Q3 2024 operating income increased 101.4 percent year over year or $86,700,000 from a negative $85,500,000 to a positive $1,200,000 and operating income for the 9 months ending September 30 increased $95,100,000 from a negative $89,600,000 to a positive 5,500,000 dollars The prior year Q3 and prior year 9 months results included an impairment loss of $89,000,000 $99,000,000 respectively compared to $922,000 in the current year quarter and current year to date. Interest expense decreased $353,000 year over year to $6,100,000 and decreased $2,000,000 year to date compared to the same period a year ago, reflecting the benefit of debt reductions throughout 2023. We ended the Q3 with total debt of $267,000,000 down from the original $300,000,000 of debt issued at the beginning of 2021. And as Caroline noted at the start of the call, we completed our exchange new notes and tender offer on October 8, 2024 and pro form a for the transaction, our quarter end debt was 220,000,000 dollars Adjusted EBITDA with the add back of one time severance expense of $1,200,000 and non cash stock based compensation of $358,000 was $5,600,000 for the quarter $15,200,000 year to date, down 6.9 percent or $414,000 for the quarter and 9.2 percent or $1,500,000 year to date.